GlobeNewswire

iPass Mobile Security Report: Half of Organizations Suspect Their Mobile Workers Have Been Hacked in the Last 12 Months

Dela

Cafes see highest number of Wi-Fi related incidents

 

REDWOOD SHORES, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- iPass Inc. (NASDAQ:IPAS), a leading provider of global mobile connectivity, today published the iPass Mobile Security Report 2018, revealing that more than half (57%) of organizations suspect their mobile workers have been hacked, or caused a mobile security issue, in the last 12 months. Overall, 81% of respondents said they had seen Wi-Fi related security incidents in the last 12 months, with cafes and coffee shops (62%) ranked as the venues where such incidents had occurred most. That was closely followed by airports (60%) and hotels (52%), with other locations on the list including train stations (30%), exhibition centers (26%), and in-flight (20%).

Compiling the responses of 500 organizations from the U.S., U.K., Germany and France, the annual iPass Mobile Security Report* provides an overview of how companies are dealing with the trade-off between security and the need to enable a mobile workforce. Many organizations have now implemented Bring Your Own Device (BYOD) policies to empower their mobile workers. However, for all the positives this can bring, 94% of enterprises said BYOD has increased mobile security risks. Overall, 92% of organizations said they were concerned their growing mobile workforce presents an increasing number of mobile security challenges.

"There is no escaping the fact that mobile security threats are rising. So while it is great that mobile workers are increasingly able to work from locations such as cafes, hotels and airports, there is no guarantee the Wi-Fi hotspot they are using is fully secure," said Raghu Konka, vice president of engineering at iPass. "Given the amount of high-profile security breaches in recent years, it's not surprising this issue is on the radar of CIOs. The conundrum remains: how can they keep their mobile workers secure while providing them with the flexibility to get connected anywhere using their device of choice?"

The research shows the majority of organizations are still addressing mobile security problems by banning employee usage of free Wi-Fi hotspots. More than a quarter (27%) take the hardline approach of banning their use at all times, while 40% ban their use sometimes. A further 16% plan to introduce a ban on public Wi-Fi hotspots in the future.

Many organizations use virtual private networks (VPN) to provide secure remote access to their data and systems, and the research shows that employee usage of VPNs is slowly increasing. In 2016, the iPass Mobile Security Report revealed that 26% of organizations were fully confident their mobile workers were using a VPN every time they went online, but that figure has jumped to 46% in 2018. However, that still leaves more than half (54%) of respondents reporting they still aren't fully confident their mobile workers use a VPN every time they go online.

Highlights from the report, categorized by geographic region, include:

  • CIOs from Germany (71%) are the most suspicious that their mobile workers have been hacked or caused a security issue.
  • U.K. enterprises are likely to be the most wary of employees working from cafes/coffee shops, as (81%) have seen Wi-Fi related security incidents occur in such a location. Meanwhile, alarm bells could ring for enterprises from the U.S. when their employees come online in airports, as 68% have seen an incident occur there.
  • In the U.K., almost half (42%) of enterprises have no plans to ban the use of free Wi-Fi hotspots. This is significantly higher compared to the U.S. (9%), Germany (10%), and France (12%).
  • U.K. organizations (38%) were least confident that their mobile workers are using a VPN every time they go online. The figure is higher in Germany (53%), U.S. (49%) and France (41%).

"While putting a blanket ban on accessing public Wi-Fi hotspots could initially appear to stop the security problem at the source, the fact of the matter is that mobile workers will stop at nothing to get themselves online. There's no point in putting roadblocks in their way without also providing a solution," added Konka. "Organizations must focus on taking positive action to resolve the security problems mobile workers are bringing to the table. With a secure connection through a VPN, enterprises can have confidence that Wi-Fi hotspot usage will have a positive rather than negative impact on their business. The key for organizations is to educate mobile workers about today's security threats, and to provide them with the tools to remain productive and secure."

*The research was carried out by independent market research company Vanson Bourne during February and March 2018. The sample comprised 500 CIO and IT decision makers from the U.S. (200), U.K. (100), Germany (100) and France (100).

About iPass Inc.

iPass (NASDAQ:IPAS) is a leading provider of global mobile connectivity, offering simple, secure, always-on Wi-Fi access on any mobile device. Built on a software-as-a-service (SaaS) platform, the iPass cloud-based service keeps its customers connected by providing unlimited Wi-Fi connectivity on unlimited devices. iPass is the world's largest Wi-Fi network, with more than 64 million hotspots around the globe, at airports, hotels, train stations, convention centers, outdoor venues, inflight, and more. Using patented technology, the iPass SmartConnect(TM) platform takes the guesswork out of Wi-Fi, automatically connecting customers to the best hotspot for their needs. Customers simply download the iPass SmartConnect app to experience unlimited, everywhere, and invisible Wi-Fi.

iPass® is a registered trademark of iPass Inc. Wi-Fi® is a registered trademark of the Wi-Fi Alliance. All other trademarks are owned by their respective owners.

iPass Media Contact
Spark Communications
Alex Crawshaw
Tel: +44 (0) 20 7436 0420
Email: ipass@sparkcomms.co.uk 

iPass IR Contacts
Kirsten Chapman / Becky Herrick
LHA Investor Relations
Tel: +1-415-433-3777
Email: ipass@lhai.com 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: iPass, Inc. via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum